BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1406237)

  • 41. Issues in Australian contaminated land risk assessment toxicology.
    Clay J; Thompson B
    J Toxicol Environ Health A; 2007 Oct; 70(19):1635-7. PubMed ID: 17763081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormesis and toxicological risk assessment.
    Rodricks JV
    Toxicol Sci; 2003 Feb; 71(2):134-6. PubMed ID: 12563098
    [No Abstract]   [Full Text] [Related]  

  • 43. [Urgent problems of hygienic standards for carcinogenic substances].
    Sidorenko GI; Litvinov NN
    Gig Sanit; 1977 Feb; (2):82-8. PubMed ID: 852697
    [No Abstract]   [Full Text] [Related]  

  • 44. [Prospects of the development of research into regulating chemical carcinogens in the environment].
    Kurliandskiĭ BA; Shabad LM
    Vopr Onkol; 1979; 25(8):57-61. PubMed ID: 483703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Biological markers--a new trend in evaluating the effects of the environment on the body].
    Hanke J; Indulski J; Lutz W
    Med Pr; 1992; 43(1):63-71. PubMed ID: 1635446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design of toxicokinetic studies.
    Smith DA; Humphrey MJ; Charuel C
    Xenobiotica; 1990 Nov; 20(11):1187-99. PubMed ID: 2275214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [What is the understanding of the scientific basis and the regulatory toxicology associated with the term "not appreciable " in the risk evaluation of carcinogens].
    Dieter HH; Konietzka R; Neumann HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Aug; 50(8):1084-5. PubMed ID: 17676413
    [No Abstract]   [Full Text] [Related]  

  • 48. The use and interpretation of biomarkers of environmental genotoxicity in humans.
    Albertini RJ
    Biotherapy; 1998; 11(2-3):155-67. PubMed ID: 9677047
    [No Abstract]   [Full Text] [Related]  

  • 49. Assessing human health response in life cycle assessment using ED10s and DALYs: part 1--Cancer effects.
    Crettaz P; Pennington D; Rhomberg L; Brand K; Jolliet O
    Risk Anal; 2002 Oct; 22(5):931-46. PubMed ID: 12442990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical assessment of carcinogenic risk policy.
    Flamm WG
    Regul Toxicol Pharmacol; 1989 Jun; 9(3):216-24. PubMed ID: 2756168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. U-shaped dose-response curves: their occurrence and implications for risk assessment.
    Davis JM; Svendsgaard DJ
    J Toxicol Environ Health; 1990 Jun; 30(2):71-83. PubMed ID: 2192070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Systems analysis of toxico-kinetic laws based on the chamber modeling in the light of the tasks of hygienic toxicology].
    Katsnel'son BA; Bezel' VS; Konysheva LK
    Gig Sanit; 1992; (5-6):9-13. PubMed ID: 1398195
    [No Abstract]   [Full Text] [Related]  

  • 53. Differences in individual susceptibility to toxic effects of chemicals determine the dose-response relationship and consequences of setting exposure standards.
    Lutz WK
    Toxicol Lett; 2002 Feb; 126(3):155-8. PubMed ID: 11814700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biokinetic and toxicodynamic modelling and its role in toxicological research and risk assessment.
    Blaauboer BJ
    Altern Lab Anim; 2003; 31(3):277-81. PubMed ID: 15612871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biologically based modeling in toxicology research.
    Andersen ME; Krishnan K; Conolly RB; McClellan RO
    Arch Toxicol Suppl; 1992; 15():217-27. PubMed ID: 1510591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Environmental cancer: a report to the public, cost benefit/risk assessment.
    Barden CR
    Tex Rep Biol Med; 1978; 37():107-17. PubMed ID: 111367
    [No Abstract]   [Full Text] [Related]  

  • 57. Estimation of risks due to environmental carcinogenesis.
    Cranmer MF
    Med Pediatr Oncol; 1977; 3(2):169-98. PubMed ID: 875896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statistical measures of risk.
    Hoel DG
    Drug Metab Rev; 1982; 13(5):829-38. PubMed ID: 6754310
    [No Abstract]   [Full Text] [Related]  

  • 59. Exposures associated with cancer in humans.
    Tomatis L
    J Cancer Res Clin Oncol; 1984; 108(1):6-10. PubMed ID: 6746717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety evaluation of chemical mixtures and combinations of chemical and non-chemical stressors.
    Jonker D; Freidig AP; Groten JP; de Hollander AE; Stierum RH; Woutersen RA; Feron VJ
    Rev Environ Health; 2004; 19(2):83-139. PubMed ID: 15329008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.